Although the difference of TIGIT expression on NK cells was not statistically significant, the expression of the activating receptor DNAM-1, which shares the same ligands as inhibitory TIGIT, was downregulated on CD56dim NK cells in the AML patients (Figure 1H). The gene discussed is CD226; the disease is acute myeloid leukemia.